Pre-ROSC Intra-Nasal Cooling Effectiveness

NCT ID: NCT00808236

Last Updated: 2011-06-10

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-11-30

Study Completion Date

2009-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study was to demonstrate the safety and feasibility of early intranasal cooling prior to return of spontaneous circulation (ROSC) in the emergency medical services (EMS) environment. It was hypothesized that cooling during the resuscitation attempt would increase ROSC and subsequent survival. The study was not powered to demonstrate statistically-significant differences in any outcome parameter, but was intended as an exploratory study only.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Out of hospital cardiac arrest remains a significant cause of death. Mild hypothermia induced after resuscitation from cardiac arrest has been shown to improve neurologically intact survival. Studies in dogs and rodents have demonstrated improved outcomes when cooling is initiated intra-arrest.

The RhinoChill is a non-invasive cooling device through which rapid cooling is achieved via the intranasal delivery of an evaporative coolant into the nasopharynx. Due to its non-invasive and portable nature, the RhinoChill can be used to begin cooling earlier than other cooling devices.

Studies performed using the RhinoChill in a porcine model of cardiac arrest suggest that cooling with the RhinoChill prior to the first defibrillation attempt facilitates resuscitation and improves resuscitation rate and neurologically intact survival.

This study is being performed to assess the feasibility of using the RhinoChill device in the pre-hospital setting to improve resuscitation from cardiac arrest.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Arrest

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RhinoChill

Intra-arrest cooling with the RhinoChill during advanced cardiac life support

Group Type EXPERIMENTAL

RhinoChill

Intervention Type DEVICE

Nasal catheters are placed and cooling is begun during the resuscitation attempt

Control

Advanced cardiac life support, only

Group Type OTHER

Control

Intervention Type OTHER

Advanced cardiac life support according to American Heart Association \& European Resuscitation Council 2005 Guidelines

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

RhinoChill

Nasal catheters are placed and cooling is begun during the resuscitation attempt

Intervention Type DEVICE

Control

Advanced cardiac life support according to American Heart Association \& European Resuscitation Council 2005 Guidelines

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

intra-nasal cooling

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥18 years
* Collapse was witnessed
* No pulse
* Unresponsive to external stimuli

Exclusion Criteria

* Have an etiology of cardiac arrest due to trauma, severe bleeding, drug overdose (OD), cerebrovascular accident (CVA), drowning, smoke inhalation, electrocution, hanging
* Already hypothermic
* Head trauma
* Cannot place intra nasal catheters
* Do Not Attempt to Resuscitate (DNAR) orders
* Known or clinically apparent pregnancy
* Have a known coagulopathy (except therapeutically induced)
* Are known to have a need for supplemental oxygen
* Achieve return of spontaneous circulation (ROSC) prior to initiating cooling
* Are reached by emergency medical services (EMS) personnel more than 20 minutes after collapse
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

BeneChill, Inc

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

BeneChill

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Denise Barbut, MD

Role: STUDY_CHAIR

BeneChill, Inc

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU St Pierre

Brussels, , Belgium

Site Status

Erasme Hospital (Free University of Brussels)

Brussels, , Belgium

Site Status

CHU de Tivoli

La Louvière, , Belgium

Site Status

UZ Gasthuisberg Leuven

Leuven, , Belgium

Site Status

CHR de la Citadelle

Liège, , Belgium

Site Status

Helig Hartzieknehuis Roeselare

Roeselare, , Belgium

Site Status

Faculty Hospital Královské Vinohrady

Prague, , Czechia

Site Status

Medizinisches Zentrum Kreis Aachen gGmbH

Aachen, , Germany

Site Status

Charite Campus Virchow Klinikum

Berlin, , Germany

Site Status

Albert Ludwigs University Freiburg

Freiburg im Breisgau, , Germany

Site Status

Georg August-Universität Göttingen

Göttingen, , Germany

Site Status

Krankenhaus Martha-Maria Halle-Dölau gGmbH

Halle, , Germany

Site Status

Otto-von-Guericke-Universität Magdeburg

Magdeburg, , Germany

Site Status

A.O Ospedale San Gerardo di Monza

Monza, , Italy

Site Status

Stockholm Prehospital Centrum

Stockholm, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium Czechia Germany Italy Sweden

References

Explore related publications, articles, or registry entries linked to this study.

Tsai MS, Barbut D, Tang W, Wang H, Guan J, Wang T, Sun S, Inderbitzen B, Weil MH. Rapid head cooling initiated coincident with cardiopulmonary resuscitation improves success of defibrillation and post-resuscitation myocardial function in a porcine model of prolonged cardiac arrest. J Am Coll Cardiol. 2008 May 20;51(20):1988-90. doi: 10.1016/j.jacc.2007.12.057. No abstract available.

Reference Type BACKGROUND
PMID: 18482670 (View on PubMed)

Castren M, Nordberg P, Svensson L, Taccone F, Vincent JL, Desruelles D, Eichwede F, Mols P, Schwab T, Vergnion M, Storm C, Pesenti A, Pachl J, Guerisse F, Elste T, Roessler M, Fritz H, Durnez P, Busch HJ, Inderbitzen B, Barbut D. Intra-arrest transnasal evaporative cooling: a randomized, prehospital, multicenter study (PRINCE: Pre-ROSC IntraNasal Cooling Effectiveness). Circulation. 2010 Aug 17;122(7):729-36. doi: 10.1161/CIRCULATIONAHA.109.931691. Epub 2010 Aug 2.

Reference Type DERIVED
PMID: 20679548 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BC-CP1012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.